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ABSTRACT
CONTEXT: Tricyclic antidepressive agents are widely used in suicide attempts and present a variety of 
deleterious effects. Rhabdomyolysis is a rare complication of such poisoning. 
CASE REPORT: A 55-year-old woman ingested 120 pills of 25 mg clomipramine in a suicide attempt two 
days before admission. After gastric lavage in another emergency department on the day of intake, 80 pills 
were removed. On admission to our department, she was disoriented, complaining of a dry mouth and 
tremors at the extremities. An electrocardiogram showed a sinus rhythm with narrow QRS complexes. Lab-
oratory results showed high creatine phosphokinase (CK = 15,094 U/l on admission; normal range = 26 to 
140 U/l), hypocalcemia, slightly increased serum transaminases and mild metabolic acidosis. The patient’s 
medical history included depression with previous suicide attempts, obsessive-compulsive disorder, 
hypothyroidism and osteoporosis. She presented cardiac arrest with pulseless electric activity for seven 
minutes and afterwards, without sedation, showed continuous side-to-side eye movement. She devel-
oped refractory hypotension, with need for vasopressors. Ceftriaxone and clindamycin administration was 
started because of a hypothesis of bronchoaspiration. The patient remained unresponsive even without 
sedation, with continuous side-to-side eye movement and a decerebrate posture. She died two months 
later. Rhabdomyolysis is a very rare complication of poisoning due to tricyclic drugs. It had only previously 
been described after an overdose of cyclobenzaprine, which has a toxicity profile similar to tricyclic drugs. 
CONCLUSIONS: Although arrhythmia is the most important complication, rhabdomyolysis should be in-
vestigated in cases of clomipramine poisoning.
RESUMO
CONTEXTO: Antidepressivos tricíclicos são amplamente utilizados em tentativas de suicídio e apresentam 
diversos efeitos deletérios, sendo a rabdomiólise uma complicação rara dessa intoxicação.
RELATO DO CASO: Uma mulher de 55 anos ingeriu 120 comprimidos de clomipramina de 25 mg numa 
tentativa de suicídio dois dias antes da admissão. Após lavagem gástrica em outro serviço de urgência no 
dia da ingestão, 80 comprimidos foram retirados. Na admissão em nosso serviço, a paciente estava deso-
rientada, queixando-se de boca seca e tremores de extremidades. O eletrocardiograma mostrou ritmo si-
nusal com complexos QRS estreitos. Exames laboratoriais evidenciaram aumento de creatinofosfoquinase 
(CK = 15.094 U/L na admissão; intervalo da normalidade = 26 a 140 U/L), hipocalcemia, discreto aumento 
das transaminases e leve acidose metabólica. Antecedentes pessoais incluíam depressão com tentativas 
de suicídio prévias, transtorno obsessivo compulsivo, hipotireoidismo e osteoporose. A paciente apresen-
tou parada cardiorrespiratória com atividade elétrica sem pulso por sete minutos e, posteriormente, sem 
sedação, foi observado olhar em varredura. A paciente evoluiu com hipotensão refratária, necessitando de 
vasopressores. Ceftriaxone e clindamicina foram iniciados pela hipótese de broncoaspiração. A paciente 
permaneceu irresponsiva mesmo sem sedação, com olhar em varredura contínuo e postura descerebra-
da. A paciente evoluiu para óbito dois meses após. Rabdomiólise é uma complicação rara da intoxicação 
por tricíclicos, e só foi descrita em overdose de ciclobenzaprina, a qual tem um perfil de toxicidade seme-
lhante aos tricíclicos.
CONCLUSÕES: Apesar de as arritmias serem as complicações mais temidas, rabdomiólise deve ser inves-
tigada em casos de intoxicação por clomipramina.
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INTRODUCTION
Tricyclic antidepressants are among the most commonly used 
drugs in suicide attempts, along with benzodiazepines, alcohol 
and acetaminophen,1 surpassed only by analgesics.2,3 Around 300 
people die each year in the United Kingdom due to tricyclic poi-
soning.4 Although the risk of suicide is the same between tricyclic 
drugs and other antidepressants, the death rates are higher when 
tricyclic drugs are used: 97% of all deaths due to antidepressant 
poisoning are caused by them.5
The case reported here forms an example of the range of clo-
mipramine toxicity, and highlights an extremely rare complica-
tion: rhabdomyolysis.
CASE REPORT
A 55-year-old woman was brought into the emergency room 
after reportedly ingesting 120 pills of 25 mg clomipramine in a 
suicide attempt two days before admission. Gastric lavage was 
performed a few hours after the ingestion in another emergency 
department, and 80 pills were removed. On admission to our ser-
vice, she was awake, but disoriented, complaining of a dry mouth 
and tremors at the extremities. Her pupils were equal and reac-
tive; she was dehydrated; and her vital signs were 86 bpm and 
122/74 mmHg. An electrocardiogram showed a sinus rhythm 
with narrow QRS complexes.
Laboratory results showed high creatine phosphokinase 
(CK = 15,094 U/l on admission; normal range = 26 to 140 U/l), 
hypocalcemia (ionized calcium = 1.05 mmol/l; normal range = 
1.15 to 1.32 mmol/l), slightly increased serum transaminases 
(alanine aminotransferase = 130 U/l, aspartate aminotrans-
ferase = 176 U/l; normal ranges are up to 31 and up to 32 U/l, 
respectively) and mild metabolic acidosis (bicarbonate content in 
venous blood = 19.5 mmol/l; normal range = 22 to 26 mmol/l). 
TSH and free T4 levels were within the normal ranges. Troponin 
I = 0.03 ng/ml (normal values are up to 0.04 ng/ml); urine analy-
sis presented pH = 5.0. 
The patient’s medical history included depression with pre-
vious suicide attempts, obsessive-compulsive disorder, hypothy-
roidism and osteoporosis. The psychoactive drugs that had been 
used to treat depression were clomipramine and fluoxetine. 
On the day of admission, the patient presented cardiac arrest 
with pulseless electric activity for seven minutes, which was 
treated in accordance with the Advanced Cardiac Life Support 
protocol, in the emergency department. A total of 100 mEq of 
sodium bicarbonate was administered. Spontaneous circula-
tion returned, with sinus bradycardia and narrow QRS com-
plexes, which were reversed with atropine. On the following 
day, after sedation was turned off, there was only a response 
to painful stimuli. The patient was admitted to the intensive 
care unit without sedation, showing continuous side-to-side 
eye movement. The tremors at the extremities and in the lips 
ceased after benzodiazepine administration. The first cranial 
computed tomography scan, produced two days after the car-
diac arrest, showed signs of brain swelling, without cerebellar 
tonsil herniation.
The patient’s urine was alkaline (pH = 7.0), and, since she 
had been receiving vigorous volume expansion since admission, 
acute renal failure did not occur. The creatine phosphokinase 
levels decreased and, one week after the ingestion, the CK level 
was 385 U/l.
A chest X-ray subsequent to the cardiac arrest revealed 
alveolar opacity in the left hemithorax and in the lower right 
hemithorax, and also diffuse bronchi and low PaO2/FiO2 ratio. 
Ceftriaxone and clindamycin administration was started 
because of a hypothesis of bronchoaspiration. The patient devel-
oped refractory hypotension, with the need for vasopressors.
Even after cessation of midazolam and fentanyl administra-
tion, the patient remained unresponsive, with continuous side-
to-side eye movement and a decerebrate posture. Midazolam 
use was resumed, and was maintained continuously thereaf-
ter, in order to inhibit status epilepticus. The cranial computed 
tomography scan was repeated 48 hours after the first one, and 
no changes were observed. After it had been determined that 
the neurological prognosis was unfavorable due to anoxic brain 
damage, palliative care was instituted, and the patient died two 
months later.
DISCUSSION
Tricyclic toxicity is due to four main pharmacological properties: 
anticholinergic effect, noradrenaline reuptake inhibition, alpha 
adrenergic receptor blockade and quinidine-like effects that 
block sodium channels.6 Despite conflicting data,7 there seem to 
be differences in the toxic levels of tricyclic drugs, since it has 
been described that clomipramine, amitriptyline, imipramine 
and trimipramine present higher death rates.8,9
Although data concerning the minimum toxic dose are 
scarce, some studies have correlated moderate toxicity with 
doses of 600 to 750 mg of clomipramine, while doses above 
750 mg have been correlated with severe complications.10,11 
Our patient ingested a higher dose, (3,000 mg) that was capa-
ble of causing severe poisoning, even after gastric lavage. 
Decontamination brings benefits for up to one hour after inges-
tion, and there is no difference between gastric lavage and use 
of activated charcoal.12,13
Inhibition of sodium channels delays depolarization, not only 
in the myocardium, but also in the conduction system. However, 
the incidence of severe dysrhythmias is low, ranging from 1.3% 
to 2.6%.14,15 QRS duration (> 0.16 seconds) is a better predictor 
of ventricular dysrhythmias and seizures than is tricyclic plasma 
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level itself,16 and it is possible for a patient to present normal QRS 
duration in spite of a high tricyclic plasma level,17 such as we have 
described in this case.
Late toxicity has been reported, mainly involving conduction 
disturbance, dysrhythmias and even death after clinical improve-
ment and stabilization.18-20 Nonetheless, it is not known whether 
these late effects are due to direct toxicity or to complications due 
to hospitalization.
It is important to highlight that rhabdomyolysis is a very 
rare complication of tricyclic antidepressive agents,21 and its 
physiopathology has not been clarified yet (Table 1). It has been 
described after cyclobenzaprine overdose, which has a range of 
toxicity similar to that of tricyclic antidepressant overdoses.22,23 
Furthermore, there have been a few cases of serotonin syndrome 
that presented with rhabdomyolysis after an overdose of clomip-
ramine and moclobemide.24,25 In all of these cases, the treatment 
consists of removing the drug, which may require dialysis, and 
clinical support.  
CONCLUSION
Tricyclic drugs are widely used in suicide attempts and present 
several toxic effects. Even though dysrhythmia is the most worri-
some complication, rhabdomyolysis should be remembered and 
investigated in cases of clomipramine poisoning.
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